Cell Signaling Market by Type (Endocrine,
Paracrine), Pathway (Akt, AMPK, Hedgehog,
Notch), Product (Consumables, Instruments),
Technology (Flow Cytometry, ELISA, Mass
Spectrometry) & Application (Research, Cancer,
Immunology) - Global Forecast to 2022
No of Pages – 215
Publishing Date - May 12, 2017
Browse detailed TOC, Tables, Figures, Charts in Cell Signaling Market by Type (Endocrine,
Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments),
Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer,
Immunology) - Global Forecast to 2022 at - https://www.absolutereports.com/10797558
The cell signaling market is expected to reach USD 3.51 billion by 2022 from USD 2.53 billion in
2017, at a CAGR of 6.8%. Factors such as increasing incidence of various chronic diseases; rising
funding for cell-based research activities; introduction of innovative and advanced instruments; and
growing biotech and biopharmaceutical industries are driving the global cell signaling market.
The cell signaling market is categorized based on type, product, technology, pathway, application,
and region. The type segment includes endocrine, paracrine, autocrine, juxtacrine, and other types
(neuronal and intracrine signaling). The endocrine segment is estimated to account the largest share
of the cell signaling market in 2017.
By product, the cell signaling market is categorized into consumables (antibodies, reagents, assay
kits and other consumables) and instruments. In 2017, the consumables segment is estimated to
account the largest share of the market.
The technology segment of the cell signaling market includes microscopy, western blotting,
immunohistochemistry (IHC), flow cytometry, enzyme-linked immunosorbent assay (ELISA), mass
spectrometry, and other technologies (immunofluorescence and immunoprecipitation). The
microscopy segment is estimated to account for the largest share of the cell signaling market in 2017.
On the basis of the pathway, the cell signaling market is categorized into Akt, AMP-activated protein
kinase (AMPK), ErbB/HER, Hedgehog (Hh), Janus kinase and signal transducer and activator of
transcription (JAK/STAT), NF-?B, Notch, and other signaling pathways. In 2017, the Akt segment is
estimated to account the largest share of the cell signaling market.
The application segment of cell signaling market includes research applications (cancer research,
immunology research, stem cells research, and other research applications) and medical applications.